Suppr超能文献

在肠吻合动物模型上给予替度鲁肽后的组织生长因子概况。

Tissular growth factors profile after teduglutide administration on an animal model of intestinal anastomosis.

作者信息

Costa Beatriz Pinto, Gonçalves Ana Cristina, Abrantes Ana Margarida, Alves Raquel, Matafome Paulo, Seiça Raquel, Sarmento-Ribeiro Ana Bela, Botelho Maria Filomena, Castro-Sousa Francisco

机构信息

"A" Surgical Department, Hospitais da Universidade de Coimbra, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

出版信息

Nutr Hosp. 2018 Jan 16;35(1):185-193. doi: 10.20960/nh.1326.

Abstract

BACKGROUND

Teduglutide is an enterotrophic analogue of glucagon-like peptide-2, with an indirect and poorly understood mechanism of action, approved for the rehabilitation of short-bowel syndrome. This study aims to analyze the response of tissue growth factors to surgical injury and teduglutide administration on an animal model of intestinal anastomosis.

METHODS

Wistar rats (n = 59) were distributed into four groups: "ileal resection" or "laparotomy", each one subdivided into "postoperative teduglutide administration" or "no treatment"; and sacrificed at the third or the seventh day, with ileal sample harvesting. Gene expression of insulin-like growth factor 1 (Igf1), vascular endothelial growth factor a (Vegfa), transforming growth factor β1 (Tgfβ1), connective tissue growth factor (Ctgf), fibroblast growth factor 2 (Fgf2), fibroblast growth factor 7 (Fgf7), epidermal growth factor (Egf), heparin-binding epidermal-like growth factor (Hbegf), platelet-derived growth factor b (Pdgfb) and glucagon-like peptide 2 receptor (Glp2r)was studied by real-time polymerase chain reaction.

RESULTS

Upregulation of Fgf7, Fgf2, Egf, Vegfaand Glp2rat the third day and of Pdgfat the seventh day was verified in the perianastomotic segment. Teduglutide administration was associated with higher fold-change of relative gene expression of Vegfa(3.6 ± 1.3 vs.1.9 ± 2.0, p = 0.0001), Hbegf(2.2 ± 2.3 vs. 1.1 ± 0.9, p = 0.001), Igf1(1.6 ± 7.6 vs. 0.9 ± 0.7, p = 0.002) and Ctgf(1.1 ± 2.1 vs. 0.6 ± 2.0, p = 0.013); and lower fold-change of Tgfβ1, Fgf7and Glp2r.

CONCLUSIONS

Those results underscore the recognized role of Igf1and Hbegfas molecular mediators of the effects of teduglutide and suggest that other humoral factors, like Vegfand Ctgf, may also be relevant in the perioperative context. Induction of Vegfa, Igf1and Ctgfgene expressions might indicate a favorable influence of teduglutide on the intestinal anastomotic healing.

摘要

背景

替度鲁肽是胰高血糖素样肽-2的肠营养类似物,其作用机制间接且了解甚少,已被批准用于短肠综合征的康复治疗。本研究旨在分析组织生长因子对肠吻合动物模型手术损伤及替度鲁肽给药的反应。

方法

将59只Wistar大鼠分为四组:“回肠切除”组或“剖腹术”组,每组再分为“术后给予替度鲁肽”组或“未治疗”组;并在第三天或第七天处死,采集回肠样本。通过实时聚合酶链反应研究胰岛素样生长因子1(Igf1)、血管内皮生长因子a(Vegfa)、转化生长因子β1(Tgfβ1)、结缔组织生长因子(Ctgf)、成纤维细胞生长因子2(Fgf2)、成纤维细胞生长因子7(Fgf7)、表皮生长因子(Egf)、肝素结合表皮样生长因子(Hbegf)、血小板衍生生长因子b(Pdgfb)和胰高血糖素样肽2受体(Glp2r)的基因表达。

结果

在吻合口周围段,第三天Fgf7、Fgf2、Egf、Vegfa和Glp2r上调,第七天Pdgfb上调得到证实。给予替度鲁肽与Vegfa相对基因表达的更高倍数变化相关(3.6±1.3对1.9±2.0,p = 0.0001)、Hbegf(2.2±2.3对1.1±0.9,p = 0.001)、Igf1(1.6±7.6对0.9±0.7,p = 0.002)和Ctgf(1.1±2.1对0.6±2.0,p = 0.013);以及Tgfβ1、Fgf7和Glp2r的更低倍数变化。

结论

这些结果强调了Igf1和Hbegf作为替度鲁肽作用的分子介质的公认作用,并表明其他体液因子,如Vegf和Ctgf,在围手术期也可能相关。Vegfa、Igf1和Ctgf基因表达的诱导可能表明替度鲁肽对肠吻合口愈合有有利影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验